OCUL
Ocular Therapeutix, Inc. · Healthcare
COO Donald Notman sold $103K of Ocular Therapeutix, Inc.
Sold$103,472
$9.04Price
11,446Shares
−3%Stake
What OCUL did after the filing
- The stock from Tue, Feb 17 close, $6.99
- +21.2%
- S&P 500, same days
- −4.8%
Measured over 30 trading days, to the Mar 31 close.
Traded Thu, Feb 12. Filed Tue, Feb 17, 3:31 PM ET, during the session. Returns use the Feb 17 close and the Mar 31 close. Not investment advice.